Despite advances in targeted therapy and immune checkpoint inhibitors (ICIs), durable disease control remains elusive for most patients with non-small cell lung cancer (NSCLC), particularly those with advanced-stage disease. Therapeutic cancer vaccines offer the potential for sustained immune surveillance by inducing t...
Wei-Jing Liu, Jie-Fei Han, K. Fei et al.· Chinese Medical Journal - Pu...· 4 citations
A high-resolution single-cell transcriptomic atlas of the ESCC tumor microenvironment is constructed via single-cell RNA sequencing of 15 tissue specimens derived from 8 ESCC patients, revealing Fibro_myo_C1 as a prominent fibroblast subset associated with ESCC progression that orchestrates stromal crosstalk to drive m...
Xiao-Wei Chen, Yuan-Yuan Lei, Da-Zhi Pang et al.· Cancer Letters· 0 citations
Age, RB1/NTRK1 mutation, and secondary T790M mutation were identified as independent risk factors and integrated into a predictive model with high accuracy and establish a clinically applicable model for early prediction and risk stratification of SCLC transformation.